Skip to main content
. 2025 May 26;24:100991. doi: 10.1016/j.resplu.2025.100991

Table 4.

Summary of Findings for Critical and Important Study Outcomes.

Outcomes (Importance) Participants (Studies), n Certainty of Evidence (GRADE) RR (95% CI) ARD with Intervention
Defibrillation dose < 1.5 J/kg (I) compared to defibrillation dose approximating 2 J/kg (C) for defibrillation in children in cardiac arrest
Termination of VF/pVT
(important)
265
(2 non-randomised studies)
Very low RR 0.63
(0.14 to 2.84)
179 fewer per 1,000(from 415 fewer to 888 more)
ROSC
(critical)
266
(4 non-randomised studies)
Very low RR 1.06
(0.95 to 1.18)
51 more per 1,000(from 42 fewer to 152 more)
Survival to Hospital Discharge (critical) 225
(2 non-randomised studies)
Very low RR 1.06
(0.80 to 1.40)
29 more per 1,000(from 96 fewer to 192 more)
Defibrillation dose > 2.5 J/kg (I) compared to defibrillation dose approximating 2 J/kg (C) for defibrillation in children in cardiac arrest
Termination of VF/pVT
(important)
265
(2 non-randomised studies)
Very low RR 0.96
(0.82 to 1.13)
22 fewer per 1,000(from 99 fewer to 77 more)
ROSC
(critical)
596
(6 non-randomised studies)
Very low RR 0.95
(0.77 to 1.17)
29 fewer per 1,000(from 133 fewer to 98 more)
Survival to Hospital Discharge (critical) 225
(2 non-randomised studies)
Very low RR 1.20
(0.38 to 3.77)
82 more per 1,000(from 253 fewer to 1,000 more)

ARD: absolute risk difference; C: comparator; CI: confidence interval; GRADE: Grading of Recommendations, Assessment, Development, and Evaluation

I: intervention; RCT: randomised controlled trial; RR: risk ratio; ROSC: return of spontaneous circulation; VF: ventricular fibrillation; pVT: pulseless ventricular tachycardia.